BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 18682444)

  • 1. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Eur Heart J; 2008 Dec; 29(23):2843-50. PubMed ID: 18682444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Adv Ther; 2009 May; 26(5):531-4. PubMed ID: 19475367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
    Figiel Ł; Wraga M; Bednarkiewicz Z; Lipiec P; Smigielski J; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2011; 69(1):1-6. PubMed ID: 21267954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart fatty acid-binding protein in combination with the 80-lead body surface potential map improves early detection of acute myocardial infarction in patients who are cardiac troponin T-negative at presentation.
    Daly MJ; McCann CJ; Owens CG; Harbinson MT; Adgey JA
    J Electrocardiol; 2011; 44(4):432-8. PubMed ID: 21529821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction.
    Haltern G; Peiniger S; Bufe A; Reiss G; Gülker H; Scheffold T
    Am J Cardiol; 2010 Jan; 105(1):1-9. PubMed ID: 20102882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria.
    Collinson PO; Gaze DC; Morris F; Morris B; Price A; Goodacre S
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):273-80. PubMed ID: 16824277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated heart-type fatty acid-binding protein assay for the early diagnosis of acute myocardial infarction.
    Kim Y; Kim H; Kim SY; Lee HK; Kwon HJ; Kim YG; Lee J; Kim HM; So BH
    Am J Clin Pathol; 2010 Jul; 134(1):157-62. PubMed ID: 20551280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
    O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
    Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy, angiographic correlates and long-term risk stratification with the troponin T ultra sensitive Rapid Assay in chest pain patients at low risk for acute myocardial infarction.
    deFilippi CR; Parmar RJ; Potter MA; Tocchi M
    Eur Heart J; 1998 Nov; 19 Suppl N():N42-7. PubMed ID: 9857939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of chest pain patients in the emergency department by a nurse utilizing a point of care protocol.
    Hamilton AJ; Swales LA; Neill J; Murphy JC; Darragh KM; Rocke LG; Adgey J
    Eur J Emerg Med; 2008 Feb; 15(1):9-15. PubMed ID: 18180660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome.
    Valle HA; Riesgo LG; Bel MS; Gonzalo FE; Sanchez MS; Oliva LI
    Eur J Emerg Med; 2008 Jun; 15(3):140-4. PubMed ID: 18460953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay.
    Ecollan P; Collet JP; Boon G; Tanguy ML; Fievet ML; Haas R; Bertho N; Siami S; Hubert JC; Coriat P; Montalescot G
    Int J Cardiol; 2007 Jul; 119(3):349-54. PubMed ID: 17097752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism.
    Kaczyñska A; Pelsers MM; Bochowicz A; Kostrubiec M; Glatz JF; Pruszczyk P
    Clin Chim Acta; 2006 Sep; 371(1-2):117-23. PubMed ID: 16698008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
    J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.
    Bank IE; Dekker MS; Hoes AW; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; Timmers L; de Kleijn DP; Glatz JF; Mosterd A
    Eur Heart J Acute Cardiovasc Care; 2016 Aug; 5(4):364-74. PubMed ID: 25906779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
    Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A superior early myocardial infarction marker. Human heart-type fatty acid-binding protein.
    Chan CP; Sanderson JE; Glatz JF; Cheng WS; Hempel A; Renneberg R
    Z Kardiol; 2004 May; 93(5):388-97. PubMed ID: 15160274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.